SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Alo PL, Visca P, Botti C, Galati GM, Sebastiani V, Andreano T, Di Tondo U, Pizer ES. 2001. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol 116(1): 129134.
  • Arakawa K, Ishihara T, Oku A, Nawano M, Ueta K, Kitamura K, Matsumoto M, Saito A. 2001. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095. Br J Pharmacol 132(2): 578586.
  • Asano T, Katagiri H, Takata K, Lin JL, Ishihara H, Inukai K, Tsukuda K, Kikuchi M, Hirano H, Yazaki Y, et al. 1991. The role of N-glycosylation of GLUT1 for glucose transport activity. J Biol Chem 266(36): 2463224636.
  • Avril N, Menzel M, Dose J, Schelling M, Weber W, Janicke F, Nathrath W, Schwaiger M. 2001. Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis. J Nucl Med 42(1): 916.
  • Baer SC, Casaubon L, Younes M. 1997. Expression of the human erythrocyte glucose transporter Glut1 in cutaneous neoplasia. J Am Acad Dermatol 37(4): 575577.
  • Baron-Delage S, Mahraoui L, Cadoret A, Veissiere D, Taillemite JL, Chastre E, Gespach C, Zweibaum A, Capeau J, Brot-Laroche E, Cherqui G. 1996. Deregulation of hexose transporter expression in Caco-2 cells by ras and polyoma middle T oncogenes. Am J Physiol 270(2 Pt 1): G314G323.
  • Beaney RP. 1984. Positron emission tomography in the study of human tumors. Semin Nucl Med 14(4): 324341.
  • Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S. 1990. Molecular biology of mammalian glucose transporters. Diabetes Care 13(3): 198208.
  • Binder C, Binder L, Marx D, Schauer A, Hiddemann W. 1997. Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues. Anticancer Res 17(6D): 42994304.
  • Birnbaum MJ, Haspel HC, Rosen OM. 1986. Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc Natl Acad Sci USA 83(16): 57845788.
  • Birnbaum MJ, Haspel HC, Rosen OM. 1987. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science 235(4795): 14951498.
  • Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD. 1995. Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52(5): 459467.
  • Board M, Humm S, Newsholme EA. 1990. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem J 265(2): 503509.
  • Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, Molthoff CF. 2002. Biologic correlates of (18) fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 20(2): 379387.
  • Briasoulis E, Judson I, Pavlidis N, Beale P, Wanders J, Groot Y, Veerman G, Schuessler M, Niebch G, Siamopoulos K, Tzamakou E, Rammou D, Wolf L, Walker R, Hanauske A. 2000. Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group. J Clin Oncol 18(20): 35353544.
  • Brown RS, Wahl RL. 1993. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72(10): 29792985.
  • Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. 1996. Intratumoral distribution of tritiated-FDG in breast carcinoma: Correlation between Glut-1 expression and FDG uptake. J Nucl Med 37(6): 10421047.
  • Brown RS, Leung JY, Kison PV, Zasadny KR, Flint A, Wahl RL. 1999. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med 40(4): 556565.
  • Brown RS, Goodman TM, Zasadny KR, Greenson JK, Wahl RL. 2002. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol 29(4): 443453.
  • Burant CF, Bell GI. 1992. Mammalian facilitative glucose transporters: Evidence for similar substrate recognition sites in functionally monomeric proteins. Biochemistry 31(42): 1041410420.
  • Burant CF, Takeda J, Brot-Laroche E, Bell GI, Davidson NO. 1992. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 267(21): 1452314526.
  • Burgman P, Odonoghue JA, Humm JL, Ling CC. 2001. Hypoxia-Induced increase in FDG uptake in MCF7 cells. J Nucl Med 42(1): 170175.
  • Burt BM, Humm JL, Kooby DA, Squire OD, Mastorides S, Larson SM, Fong Y. 2001. Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia 3(3): 189195.
  • Cailleau R, Olive M, Cruciger QV. 1978. Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization. In Vitro 14(11): 911915.
  • Cantuaria G, Fagotti A, Ferrandina G, Magalhaes A, Nadji M, Angioli R, Penalver M, Mancuso S, Scambia G. 2001. GLUT-1 expression in ovarian carcinoma: Association with survival and response to chemotherapy. Cancer 92(5): 11441150.
  • Chan JY, Kong SK, Choy YM, Lee CY, Fung KP. 1999. Inhibition of glucose transporter gene expression by antisense nucleic acids in HL-60 leukemia cells. Life Sci 65(1): 6370.
  • Chandler JD, Williams ED, Slavin JL, Best JD, Rogers S. 2003. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma. Cancer 97(8): 20352042.
  • Charlier C, Chariot A, Antoine N, Merville MP, Gielen J, Castronovo V. 1995. Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells. Biochem Pharmacol 49(3): 351358.
  • Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. 2001. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276(12): 95199525.
  • Choi JW, Yoon DJ, Lee HW, Han DP, Ahn YH. 1995. Antisense GLUT1 RNA suppresses the transforming phenotypes of NIH 3T3 cells transformed by N-Ras. Yonsei Med J 36(6): 480486.
  • Chung JK, Lee YJ, Kim C, Choi SR, Kim M, Lee K, Jeong JM, Lee DS, Jang JJ, Lee MC. 1999. Mechanisms related to [18F]fluorodeoxyglucose uptake of human colon cancers transplanted in nude mice. J Nucl Med 40(2): 339346.
  • Clavo AC, Brown RS, Wahl RL. 1995. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 36(9): 16251632.
  • Colville CA, Seatter MJ, Jess TJ, Gould GW, Thomas HM. 1993. Kinetic analysis of the liver-type (GLUT2) and brain-type (GLUT3) glucose transporters in Xenopus oocytes: Substrate specificities and effects of transport inhibitors. Biochem J 290(Pt 3): 701706.
  • Dawson PA, Mychaleckyj JC, Fossey SC, Mihic SJ, Craddock AL, Bowden DW. 2001. Sequence and functional analysis of GLUT10: A glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. Mol Genet Metab 74(1–2): 186199.
  • Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP. 1982. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32(12): 13231329.
  • Doege H, Bocianski A, Joost HG, Schurmann A. 2000a. Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 350(Pt 3): 771776.
  • Doege H, Schurmann A, Bahrenberg G, Brauers A, Joost HG. 2000b. GLUT8, a novel member of the sugar transport facilitator family with glucose transport activity. J Biol Chem 275(21): 1627516280.
  • Doege H, Bocianski A, Scheepers A, Axer H, Eckel J, Joost HG, Schurmann A. 2001. Characterization of human glucose transporter (GLUT) 11 (encoded by SLC2A11), a novel sugar-transport facilitator specifically expressed in heart and skeletal muscle. Biochem J 359(Pt 2): 443449.
  • Dutu R, Nedelea M, Veluda G, Burculet V. 1980. Cytoenzymologic investigations on carcinomas of the cervix uteri. Acta Cytol 24(2): 160166.
  • Ebert BL, Firth JD, Ratcliffe PJ. 1995. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 270(49): 2908329089.
  • Flier JS, Mueckler MM, Usher P, Lodish HF. 1987. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235(4795): 14921495.
  • Fukumoto H, Seino S, Imura H, Seino Y, Bell GI. 1988. Characterization and expression of human HepG2/erythrocyte glucose-transporter gene. Diabetes 37(5): 657661.
  • Gould GW, Thomas HM, Jess TJ, Bell GI. 1991. Expression of human glucose transporters in Xenopus oocytes: Kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms. Biochemistry 30(21): 51395145.
  • Grover-McKay M, Walsh SA, Seftor EA, Thomas PA, Hendrix MJ. 1998. Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res 4(2): 115120.
  • Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz SH, Bodian C, Slater G, Weiss A, Burstein DE. 1998. GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis. Cancer 83(1): 3440.
  • Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. 2002. FDG-PET: A possible prognostic factor in head and neck cancer. Br J Cancer 86(4): 512516.
  • Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ, Sizeland A. 2002. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 236(2): 208217.
  • Hatanaka M. 1974. Transport of sugars in tumor cell membranes. Biochim Biophys Acta 355(1): 77104.
  • Helmlinger G, Yuan F, Dellian M, Jain RK. 1997. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat Med 3(2): 177182.
  • Hennipman A, Smits J, van Oirschot B, van Houwelingen JC, Rijksen G, Neyt JP, Van Unnik JA, Staal GE. 1987. Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol 8(5): 251263.
  • Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE. 1988. Glycolytic enzyme activities in breast cancer metastases. Tumour Biol 9(5): 241248.
  • Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, Honda T, Inokuma T, Katsushima S, Ohshio G, Imamura M, Konishi J. 1998. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 39(10): 17271735.
  • Higashi K, Ueda Y, Sakurai A, Wang XM, Xu L, Murakami M, Seki H, Oguchi M, Taki S, Nambu Y, Tonami H, Katsuda S, Yamamoto I. 2000. Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer. Eur J Nucl Med 27(12): 17781785.
  • Higashi T, Saga T, Nakamoto Y, Ishimori T, Mamede MH, Wada M, Doi R, Hosotani R, Imamura M, Konishi J. 2002. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43(2): 173180.
  • Horwitz KB, Costlow ME, McGuire WL. 1975. MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 26(6): 785795.
  • Ibberson M, Uldry M, Thorens B. 2000. GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues. J Biol Chem 275(7): 46074612.
  • Ikezaki K, Black KL, Conklin SG, Becker DP. 1992. Histochemical evaluation of energy metabolism in rat glioma. Neurol Res 14(4): 289293.
  • Ito S, Fukusato T, Nemoto T, Sekihara H, Seyama Y, Kubota S. 2002. Coexpression of glucose transporter 1 and matrix metalloproteinase-2 in human cancers. J Natl Cancer Inst 94(14): 10801091.
  • Joost HG, Thorens B. 2001. The extended GLUT-family of sugar/polyol transport facilitators: Nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 18(4): 247256.
  • Joost HG, Bell GI, Best JD, Birnbaum MJ, Charron MJ, Chen YT, Doege H, James DE, Lodish HF, Moley KH, Moley JF, Mueckler M, Rogers S, Schurmann A, Seino S, Thorens B. 2002. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab 282(4): E974E976.
  • Kang SS, Chun YK, Hur MH, Lee HK, Kim YJ, Hong SR, Lee JH, Lee SG, Park YK. 2002. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 93(10): 11231128.
  • Keller K, Strube M, Mueckler M. 1989. Functional expression of the human HepG2 and rat adipocyte glucose transporters in Xenopus oocytes. Comparison of kinetic parameters. J Biol Chem 264(32): 1888418889.
  • Kern KA, Norton JA. 1987. Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose. Surgery 102(2): 380385.
  • Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ. 1979. Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15(5): 659670.
  • Kurokawa T, Yoshida Y, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y, Yonekura Y, Kotsuji F. 2004. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary. Int J Cancer 109(6): 926932.
  • Laborda J. 1991. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res 19(14): 3998.
  • Lippman ME, Bolan G. 1975. Oestrogen-responsive human breast cancer in long term tissue culture. Nature 256(5518): 592593.
  • Macheda ML, Kelly DJ, Best JD, Rogers S. 2002. Expression during rat fetal development of GLUT12—A member of the class III hexose transporter family. Anat Embryol (Berl) 205(5-6): 441452.
  • Macheda ML, Williams ED, Best JD, Wlodek ME, Rogers S. 2003. Expression and localisation of GLUT1 and GLUT12 glucose transporters in the pregnant and lactating rat mammary gland. Cell Tissue Res 311(1): 9197.
  • MacManus MP, Hicks RJ, Ball DL, Ciavarella F, Binns D, Hogg A, Kalff V, Ware R, Wirth A, Salminen E, McKenzie A. 2001. Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy. Australas Radiol 45(4): 483490.
  • Mazurek S, Grimm H, Boschek CB, Vaupel P, Eigenbrodt E. 2002. Pyruvate kinase type M2: A crossroad in the tumor metabolome. Br J Nutr 87(Suppl 1): S23S29.
  • McDermott EW, Barron ET, Smyth PP, O'Higgins NJ. 1990. Premorphological metabolic changes in human breast carcinogenesis. Br J Surg 77(10): 11791182.
  • Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE, Lodish HF. 1985. Sequence and structure of a human glucose transporter. Science 229(4717): 941945.
  • Mueller H, Loop P, Liu R, Wosikowski K, Kueng W, Eppenberger U. 1994. Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells. Eur J Biochem 221(2): 631637.
  • Murakami T, Nishiyama T, Shirotani T, Shinohara Y, Kan M, Ishii K, Kanai F, Nakazuru S, Ebina Y. 1992. Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes. J Biol Chem 267(13): 93009306.
  • Nagase Y, Takata K, Moriyama N, Aso Y, Murakami T, Hirano H. 1995. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol 153(3 Pt 1): 798801.
  • Neeman M, Degani H. 1989. Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy. Cancer Res 49(3): 589594.
  • Newsholme EA, Board M. 1991. Application of metabolic-control logic to fuel utilization and its significance in tumor cells. Adv Enzyme Regul 31: 225246.
  • Nieweg OE, Kim EE, Wong WH, Broussard WF, Singletary SE, Hortobagyi GN, Tilbury RS. 1993. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 71(12): 39203925.
  • Nishioka T, Oda Y, Seino Y, Yamamoto T, Inagaki N, Yano H, Imura H, Shigemoto R, Kikuchi H. 1992. Distribution of the glucose transporters in human brain tumors. Cancer Res 52(14): 39723979.
  • Noguchi Y, Saito A, Miyagi Y, Yamanaka S, Marat D, Doi C, Yoshikawa T, Tsuburaya A, Ito T, Satoh S. 2000. Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth. Cancer Lett 154(2): 175182.
  • Ogawa J, Inoue H, Koide S. 1997. Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer. Int J Cancer 74(2): 189192.
  • Okino ST, Chichester CH, Whitlock JP, Jr. 1998. Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter. J Biol Chem 273(37): 2383723843.
  • Oshida M, Uno K, Suzuki M, Nagashima T, Hashimoto H, Yagata H, Shishikura T, Imazeki K, Nakajima N. 1998. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose. Cancer 82(11): 22272234.
  • Pedersen MW, Holm S, Lund EL, Hojgaard L, Kristjansen PE. 2001. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia 3(1): 8087.
  • Ravazoula P, Batistatou A, Aletra C, Ladopoulos J, Kourounis G, Tzigounis B. 2003. Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes. Eur J Gynaecol Oncol 24(6): 544546.
  • Rea S, James DE. 1997. Moving GLUT4: The biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 46(11): 16671677.
  • Rivenzon-Segal D, Rushkin E, Polak-Charcon S, Degani H. 2000. Glucose transporters and transport kinetics in retinoic acid-differentiated T47D human breast cancer cells. Am J Physiol Endocrinol Metab 279(3): E508E519.
  • Rivenzon-Segal D, Boldin-Adamsky S, Seger D, Seger R, Degani H. 2003. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer 107(2): 177182.
  • Rogers S, Macheda ML, Docherty SE, Carty MD, Henderson MA, Soeller WC, Gibbs EM, James DE, Best JD. 2002. Identification of a novel glucose transporter-like protein-GLUT-12. Am J Physiol Endocrinol Metab 282(3): E733E738.
  • Rogers S, Chandler JD, Clarke AL, Petrou S, Best JD. 2003a. Glucose transporter GLUT12-functional characterization in Xenopus laevis oocytes. Biochem Biophys Res Commun 308(3): 422426.
  • Rogers S, Docherty SE, Slavin JL, Henderson MA, Best JD. 2003b. Differential expression of GLUT12 in breast cancer and normal breast tissue. Cancer Lett 193(2): 225233.
  • Rudlowski C, Becker AJ, Schroder W, Rath W, Buttner R, Moser M. 2003. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer. Am J Clin Pathol 120(5): 691698.
  • Schwartz MK. 1992. Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin Chim Acta 206(1-2): 7782.
  • Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, Hinz U, Strauss LG, Zhang YM, Mechtersheimer G, Attigah N, Lehnert T, Herfarth C. 2000. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 231(3): 380386.
  • Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. 1997. c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc Natl Acad Sci USA 94(13): 66586663.
  • Singh A, Purohit A, Hejaz HA, Potter BV, Reed MJ. 2000. Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate. Mol Cell Endocrinol 160(1-2): 6166.
  • Soule HD, McGrath CM. 1980. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Lett 10(2): 177189.
  • Stein I, Neeman M, Shweiki D, Itin A, Keshet E. 1995. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15(10): 53635368.
  • Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J. 1995. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 36(10): 18111817.
  • Uldry M, Ibberson M, Horisberger JD, Chatton JY, Riederer BM, Thorens B. 2001. Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain. Embo J 20(16): 44674477.
  • Veyhl M, Wagner K, Volk C, Gorboulev V, Baumgarten K, Weber WM, Schaper M, Bertram B, Wiessler M, Koepsell H. 1998. Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1. Proc Natl Acad Sci USA 95(6): 29142919.
  • Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J, Lupu R. 2000. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol Rep 7(1): 157167.
  • Wang BY, Kalir T, Sabo E, Sherman DE, Cohen C, Burstein DE. 2000. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer 88(12): 27742781.
  • Warburg O. 1956. On the origin of cancer cells. Science 123: 309314.
  • Wilding G, Lippman ME, Gelmann EP. 1988. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Res 48(4): 802805.
  • Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T, Imura H. 1990. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170(1): 223230.
  • Yen TC, See LC, Lai CH, Yah-Huei CW, Ng KK, Ma SY, Lin WJ, Chen JT, Chen WJ, Lai CR, Hsueh S. 2004. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med 45(1): 2229.
  • Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R. 1995. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers. Anticancer Res 15(6B): 28952898.
  • Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. 1997. Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res 17(4A): 27472750.
  • Yuan Y, Hilliard G, Ferguson T, Millhorn DE. 2003. Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. J Biol Chem 278(18): 1591115916.
  • Zamora-Leon SP, Golde DW, Concha II, Rivas CI, Delgado-Lopez F, Baselga J, Nualart F, Vera JC. 1996. Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci USA 93(5): 18471852.
  • Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. 1998. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. Embo J 17(17): 50855094.
  • Zhang M, Zhang Z, Blessington D, Li H, Busch TM, Madrak V, Miles J, Chance B, Glickson JD, Zheng G. 2003. Pyropheophorbide 2-deoxyglucosamide: A new photosensitizer targeting glucose transporters. Bioconjug Chem 14(4): 709714.